{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T04:13:50Z","timestamp":1726632830850},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,16]]},"DOI":"10.7759\/cureus.69548","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:54:10Z","timestamp":1726617250000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Lymphoblastic Leukemia in a Patient With Advanced Breast Cancer Treated With Cyclin-Dependent Kinase 4\/6 Inhibitors and Endocrine Therapy"],"prefix":"10.7759","author":[{"given":"Ryan E","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Mazo Canola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1193","article-title":"Cancer progress and priorities: breast cancer","volume":"30","author":"Houghton SC","year":"2021","unstructured":"Houghton SC, Hankinson SE. Cancer progress and priorities: breast cancer. Cancer Epidemiol Biomarkers Prev. 2021, 30:822-44. 10.1158\/1055-9965.EPI-20-1193","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","article-title":"Breast cancer","author":"Memon G","year":"2024","unstructured":"Memon G, Alkabban FM, Ferguson T. Breast cancer. StatPearls Publishing, Treasure Island, USA; 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn RS","year":"2016","unstructured":"Finn RS, Martin M, Rugo HS, et al.. Palbociclib and letrozole in advanced breast cancer. N Engl J Med. 2016, 375:1925-36. 10.1056\/NEJMoa1607303","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-020-01054-7","article-title":"First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis","volume":"27","author":"Shimoi T","year":"2020","unstructured":"Shimoi T, Sagara Y, Hara F, Toyama T, Iwata H. First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer. 2020, 27:340-6. 10.1007\/s12282-020-01054-7","journal-title":"Breast Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0142","article-title":"Clinical management of potential toxicities and drug interactions related to cyclin-dependent kinase 4\/6 inhibitors in breast cancer: practical considerations and recommendations","volume":"22","author":"Spring LM","year":"2017","unstructured":"Spring LM, Zangardi ML, Moy B, Bardia A. Clinical management of potential toxicities and drug interactions related to cyclin-dependent kinase 4\/6 inhibitors in breast cancer: practical considerations and recommendations. Oncologist. 2017, 22:1039-48. 10.1634\/theoncologist.2017-0142","journal-title":"Oncologist"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger T","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017, 7:e577. 10.1038\/bcj.2017.53","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores GM","year":"2012","unstructured":"Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012, 119:34-43. 10.1182\/blood-2011-04-347872","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2005.00513.x","article-title":"A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL)","volume":"14","author":"Redaelli A","year":"2005","unstructured":"Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005, 14:53-62. 10.1111\/j.1365-2354.2005.00513.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou S","year":"2011","unstructured":"Ducassou S, Ferlay C, Bergeron C, et al.. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. Br J Haematol. 2011, 152:441-51. 10.1111\/j.1365-2141.2010.08541.x","journal-title":"Br J Haematol"},{"key":"ref10","unstructured":"WHO classification of tumours of haematopoietic and lymphoid tissues. (2017). Accessed. February 24, 2023: https:\/\/www.iarc.who.int\/news-events\/who-classification-of-tumours-of-haematopoietic-and-lymphoid-tissues-2\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.29","article-title":"Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031","volume":"28","author":"Schultz KR","year":"2014","unstructured":"Schultz KR, Devidas M, Bowman WP, et al.. Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031. Leukemia. 2014, 28:964-7. 10.1038\/leu.2014.29","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-832105","article-title":"How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"133","author":"Ravandi F","year":"2019","unstructured":"Ravandi F. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2019, 133:130-6. 10.1182\/blood-2018-08-832105","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian HM","year":"2000","unstructured":"Kantarjian HM, O'Brien S, Smith TL, et al.. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000, 18:547-61. 10.1200\/JCO.2000.18.3.547","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01510-6","article-title":"Cellular mechanisms underlying response and resistance to CDK4\/6 inhibitors in the treatment of hormone receptor-positive breast cancer","volume":"24","author":"Watt AC","year":"2022","unstructured":"Watt AC, Goel S. Cellular mechanisms underlying response and resistance to CDK4\/6 inhibitors in the treatment of hormone receptor-positive breast cancer. Breast Cancer Res. 2022, 24:17. 10.1186\/s13058-022-01510-6","journal-title":"Breast Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy109","article-title":"Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR+\/HER2- advanced breast cancer","volume":"111","author":"Di\u00e9ras V","year":"2019","unstructured":"Di\u00e9ras V, Rugo HS, Schnell P, et al.. Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR+\/HER2- advanced breast cancer. J Natl Cancer Inst. 2019, 111:419-30. 10.1093\/jnci\/djy109","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.8724","article-title":"Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"30","author":"Dunsmore KP","year":"2012","unstructured":"Dunsmore KP, Devidas M, Linda SB, et al.. Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. J Clin Oncol. 2012, 30:2753-9. 10.1200\/JCO.2011.40.8724","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-292615","article-title":"Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)","volume":"118","author":"Asselin BL","year":"2011","unstructured":"Asselin BL, Devidas M, Wang C, et al.. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). Blood. 2011, 118:874-83. 10.1182\/blood-2010-06-292615","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031","volume":"28","author":"Schultz KR","year":"2014","unstructured":"Schultz KR, Carroll A, Heerema NA, et al.. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. Leukemia. 2014, 28:1467-71. 10.1038\/leu.2014.30","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-022-02542-3","article-title":"Efficacy of chemotherapy for comorbid cancer in patients with simultaneous double cancers: a multicenter study","volume":"53","author":"Sohda M","year":"2023","unstructured":"Sohda M, Yokobori T, Kimura A, et al.. Efficacy of chemotherapy for comorbid cancer in patients with simultaneous double cancers: a multicenter study. Surg Today. 2023, 53:98-108. 10.1007\/s00595-022-02542-3","journal-title":"Surg Today"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268587-acute-lymphoblastic-leukemia-in-a-patient-with-advanced-breast-cancer-treated-with-cyclin-dependent-kinase-46-inhibitors-and-endocrine-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:54:13Z","timestamp":1726617253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268587-acute-lymphoblastic-leukemia-in-a-patient-with-advanced-breast-cancer-treated-with-cyclin-dependent-kinase-46-inhibitors-and-endocrine-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.69548","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}